bupranolol has been researched along with metoprolol in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL | 1 |
Amend, A; Candelore, MR; Cascieri, MA; Deng, L; Guan, XM; Liu, Y; Newbold, R; Tota, L; Weber, AE | 1 |
Baker, JG | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Edmonds, D; Jeck, T; Mengden, T; Renz, I; Schubert, M; Vetter, W; Weisser, B | 1 |
Komar, K; Tarnow, J | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Biro, G; Kindermann, W; Salas-Fraire, O; Schnabel, A; Steinkraus, V | 1 |
1 review(s) available for bupranolol and metoprolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
1 trial(s) available for bupranolol and metoprolol
Article | Year |
---|---|
Metabolic and hormonal responses to exhaustive supramaximal running with and without beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Bupranolol; Epinephrine; Fatigue; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Male; Metoprolol; Norepinephrine; Plasma Volume; Running | 1984 |
7 other study(ies) available for bupranolol and metoprolol
Article | Year |
---|---|
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea | 1999 |
Potent and selective human beta(3)-adrenergic receptor antagonists.
Topics: Adipocytes; Adrenergic beta-Antagonists; Aminophenols; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Ligands; Lipolysis; Macaca mulatta; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Sulfonamides | 1999 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Pressure; Bupranolol; Cholesterol; Drug Eruptions; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Patient Compliance | 1992 |
Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bupranolol; Dobutamine; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Revascularization; Premedication; Sotalol | 1988 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |